USEFULNESS OF PROGRAMMED STIMULATION IN PREDICTING EFFICACY OF PROPAFENONE IN LONG-TERM ANTIARRHYTHMIC THERAPY FOR PAROXYSMAL SUPRAVENTRICULAR TACHYCARDIA

被引:36
作者
MANZ, M
STEINBECK, G
LUDERITZ, B
机构
关键词
D O I
10.1016/0002-9149(85)91017-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:593 / 597
页数:5
相关论文
共 20 条
[1]   MECHANISMS OF ATRIOVENTRICULAR JUNCTIONAL TACHYCARDIA - ROLE OF REENTRY AND CONCEALED ACCESSORY BYPASS TRACTS [J].
BAROLD, SS ;
COUMEL, P .
AMERICAN JOURNAL OF CARDIOLOGY, 1977, 39 (01) :97-106
[2]   SERIAL ELECTROPHYSIOLOGIC TESTING OF MULTIPLE-DRUGS IN PATIENTS WITH ATRIOVENTRICULAR NODAL REENTRANT PAROXYSMAL TACHYCARDIA [J].
BAUERNFEIND, RA ;
WYNDHAM, CR ;
DHINGRA, RC ;
SWIRYN, SP ;
PALILEO, E ;
STRASBERG, B ;
ROSEN, KM .
CIRCULATION, 1980, 62 (06) :1341-1349
[3]  
BECK OA, 1978, DEUT MED WOCHENSCHR, V32, P1261
[4]   EFFECT OF PROPAFENONE IN THE WOLFF-PARKINSON-WHITE SYNDROME - ELECTROPHYSIOLOGIC FINDINGS AND LONG-TERM FOLLOW-UP [J].
BREITHARDT, G ;
BORGGREFE, M ;
WIEBRINGHAUS, E ;
SEIPEL, L .
AMERICAN JOURNAL OF CARDIOLOGY, 1984, 54 (09) :D29-D39
[5]  
CONOLLY S, 1983, CIRCULATION, V68, P589
[6]   PREEXCITATION SYNDROMES [J].
GALLAGHER, JJ ;
PRITCHETT, ELC ;
SEALY, WC ;
KASELL, J ;
WALLACE, AG .
PROGRESS IN CARDIOVASCULAR DISEASES, 1978, 20 (04) :285-327
[7]   EFFECTS OF PROPAFENONE ON INDUCTION AND MAINTENANCE OF ATRIOVENTRICULAR NODAL REENTRANT TACHYCARDIA [J].
GARCIACIVERA, R ;
SANJUAN, R ;
MORELL, S ;
FERRERO, JA ;
MIRALLES, L ;
LLAVADOR, J ;
LOPEZMERINO, V .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1984, 7 (04) :649-655
[8]   COMPARISON OF THE ELECTROPHYSIOLOGIC EFFECTS OF INTRAVENOUS AND ORAL VERAPAMIL IN PATIENTS WITH PAROXYSMAL SUPRA-VENTRICULAR TACHYCARDIA [J].
KLEIN, GJ ;
GULAMHUSEIN, S ;
PRYSTOWSKY, EN ;
CARRUTHERS, SG ;
DONNER, AP ;
KO, PT .
AMERICAN JOURNAL OF CARDIOLOGY, 1982, 49 (01) :117-124
[10]   ELECTRO-PHYSIOLOGICAL AND ANTIARRHYTHMIC PROPERTIES OF PROPAFENON IN ISOLATED CARDIAC PREPARATIONS [J].
LEDDA, F ;
MANTELLI, L ;
MANZINI, S ;
AMERINI, S ;
MUGELLI, A .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1981, 3 (06) :1162-1173